Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-26-004949
Filing Date
2026-07-28
Accepted
2026-07-28 16:21:25
Documents
2
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_072826.htm 6-K 3886
2 PRESS RELEASE exh_991.htm EX-99.1 41745
  Complete submission text file 0001171843-26-004949.txt   46794
Mailing Address SCHALIENHOEVEDREEF 20T 2800 MECHELEN Belgium
Business Address SCHALIENHOEVEDREEF 20T 2800 MECHELEN Belgium 3215342900
Lakefront Biotherapeutics NV (Filer) CIK: 0001421876 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9
Type: 6-K | Act: 34 | File No.: 001-37384 | Film No.: 261212143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)